CVS Health Corporation (LON:0HRS)

London flag London · Delayed Price · Currency is GBP · Price in USD
78.69
-0.30 (-0.37%)
At close: Nov 7, 2025
-0.37%
Market Cap76.16B
Revenue (ttm)291.39B
Net Income (ttm)348.91M
Shares Outn/a
EPS (ttm)0.28
PE Ratio218.28
Forward PE11.33
Dividend2.03 (2.57%)
Ex-Dividend DateOct 23, 2025
Volume7,647
Average Volume5,022
Open78.38
Previous Close78.98
Day's Range78.29 - 79.40
52-Week Range43.56 - 85.80
Beta0.48
RSI49.72
Earnings DateOct 29, 2025

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1996
Employees 300,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HRS
Full Company Profile

Financial Performance

In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.

Financial numbers in USD Financial Statements

News

Can CVS Health Maintain Its Growth Through the End of 2025?

The company's prospects are looking up.

23 hours ago - The Motley Fool

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CV...

2 days ago - Business Wire

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

3 days ago - Nasdaq

CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS ...

CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continual "Buy" Rating | CVS Stock News

5 days ago - GuruFocus

Validea Detailed Fundamental Analysis - CVS

Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...

5 days ago - Nasdaq

CVS Health: Undervalued And Ripe For Growth

CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

5 days ago - Seeking Alpha

CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity

WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting ...

8 days ago - PRNewsWire

What the Options Market Tells Us About CVS Health

High-rolling investors have positioned themselves bearish on CVS Health (NYSE: CVS), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...

8 days ago - Benzinga

CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Outperform Rating | CVS Stock News

CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Outperform Rating | CVS Stock News

9 days ago - GuruFocus

CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS ...

CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance

9 days ago - GuruFocus

Guru Fundamental Report for CVS

Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...

9 days ago - Nasdaq

My Top 10 High-Yield Picks For November 2025: One Yields 9%+

I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, a...

9 days ago - Seeking Alpha

CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results

CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results

9 days ago - GuruFocus

Q3 2025 CVS Health Corp Earnings Call Transcript

Q3 2025 CVS Health Corp Earnings Call Transcript

9 days ago - GuruFocus

CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | CVS Stock News

CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | CVS Stock News

9 days ago - GuruFocus

CVS Health (CVS) Analyst Rating Update: Target Price Raised by Truist Securities | CVS Stock News

CVS Health (CVS) Analyst Rating Update: Target Price Raised by Truist Securities | CVS Stock News

9 days ago - GuruFocus

Decoding CVS Health Corp (CVS): A Strategic SWOT Insight

Decoding CVS Health Corp (CVS): A Strategic SWOT Insight

10 days ago - GuruFocus

CVS Health Reports Strong Q3 Results and Raises EPS Guidance

CVS Health Reports Strong Q3 Results and Raises EPS Guidance

10 days ago - GuruFocus

FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug

Akebia Therapeutics Inc. (NASDAQ: AKBA) stock is trading lower on Wednesday. The kidney disease company met with the U.S. Food and Drug Administration (FDA) and has not reached an agreement on a path...

10 days ago - Benzinga

CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance

CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance

10 days ago - GuruFocus

Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size

UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size

10 days ago - WSJ

CVS Health (CVS) Stock Rises on Strong Q3 Earnings and Raised Guidance

CVS Health (CVS) Stock Rises on Strong Q3 Earnings and Raised Guidance

10 days ago - GuruFocus

CVS Prioritizes Membership Growth Over Expanding Clinic Numbers

CVS Prioritizes Membership Growth Over Expanding Clinic Numbers

10 days ago - GuruFocus